Millions of persons in the United States are infected with hepatitis C virus (HCV).1 Medications that can cure chronic HCV infection in the vast majority of persons with minimal side effects and in a short duration have been available since 2013 and offer the prospect that HCV can be eliminated.2 An important metric necessary for elimination is knowing HCV prevalence at more granular levels than just nationally. This article is protected by copyright. All rights reserved.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: